DocuSign, Inc. (NASDAQ:DOCU) Insider James P. Shaughnessy Sells 7,500 Shares

DocuSign, Inc. (NASDAQ:DOCU) insider James P. Shaughnessy sold 7,500 shares of the business’s stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total value of $609,825.00. Following the sale, the insider now owns 45,875 shares of the company’s stock, valued at approximately $3,730,096.25. This represents a 14.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

DocuSign Stock Performance

Shares of NASDAQ:DOCU opened at $83.40 on Thursday. The company has a market capitalization of $16.89 billion, a P/E ratio of 17.20, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02. The company’s 50-day moving average is $86.67 and its 200 day moving average is $81.91. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86.

DocuSign (NASDAQ:DOCU) last released its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.02. The firm had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company’s revenue was up 9.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.76 EPS. As a group, research analysts predict that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Wall Street Analysts Forecast Growth

DOCU has been the subject of a number of recent research reports. Jefferies Financial Group decreased their price target on shares of DocuSign from $115.00 to $105.00 and set a “buy” rating for the company in a research note on Monday. Royal Bank of Canada reissued a “sector perform” rating and set a $90.00 target price on shares of DocuSign in a research report on Friday, March 14th. Bank of America dropped their price target on shares of DocuSign from $112.00 to $98.00 and set a “neutral” rating on the stock in a research report on Friday, March 14th. Hsbc Global Res raised DocuSign to a “moderate sell” rating in a report on Friday, December 6th. Finally, Citigroup raised their target price on DocuSign from $113.00 to $115.00 and gave the company a “buy” rating in a report on Friday, March 14th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $95.83.

Institutional Trading of DocuSign

A number of large investors have recently bought and sold shares of DOCU. Toronto Dominion Bank grew its stake in shares of DocuSign by 30.3% during the 3rd quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock worth $1,624,000 after acquiring an additional 6,081 shares during the period. Quantinno Capital Management LP boosted its position in DocuSign by 39.5% during the third quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock worth $12,514,000 after purchasing an additional 57,104 shares during the period. Rhumbline Advisers increased its stake in shares of DocuSign by 118.8% in the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company’s stock worth $54,695,000 after purchasing an additional 330,136 shares in the last quarter. KBC Group NV raised its position in shares of DocuSign by 32.7% in the fourth quarter. KBC Group NV now owns 1,535,107 shares of the company’s stock valued at $138,067,000 after purchasing an additional 378,233 shares during the period. Finally, Jennison Associates LLC purchased a new stake in shares of DocuSign during the 4th quarter valued at approximately $12,897,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.